APIs
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
APIs | Breaking News | Facilities | Industry News
Lonza Launches Early-Intermediates Supply Initiative for Small-Molecule APIs
Addresses concerns regarding over-dependence on regional supply of pharma ingredients to the Western Pharma industry09.18.18
-
APIs | Breaking News | Facilities | Industry News | Inspections
Asymchem Passes FDA Inspection at API Mfg. Site
Reports successful FDA inspection of Tianjin 2 development and commercial manufacturing facility with no Form 483 issued09.14.18
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Technology Evolution
Handling of high potency compounds for API and DP from development on a laboratory scale and scale-up to commercial.Martina Kotthaus, Jeff Dinyer, Anil Kane and Marvin Faber, Patheon, part of Thermo Fisher Scientific 09.11.18
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth.Nigel Walker, That’s Nice/Nice Insight 09.11.18
-
APIs | Bio News | Industry News | Promotions & Moves
TAPI Announces New President
John Nason joins TAPI after serving as Senior Vice President of European Technical Operations of Teva since 201509.10.18
-
APIs | Breaking News | Facilities | Industry News
Olon Acquires Manufacturing Facility in India
Includes long-term supply contract for the supply of Sandoz products manufactured in Mahad09.10.18
-
APIs | Bio News | cGMP Manufacture | Facilities | Industry News | Inspections
Novasep Announces Successful FDA Inspection
At its API development and manufacturing site in Chasse-sur-Rhône, France08.27.18
-
APIs | Industry News
-
APIs | Bio News | Facilities | Industry News | Inspections
WuXi STA Site Passes Fourth Inspection
API manufacturing facility at Jinshan also passed FDA inspection in 2013, 2014 and 201607.26.18
-
APIs | Breaking News | Excipients | Facilities | Industry News
SK Holdings Acquires Ampac Fine Chemicals
Combination strengthens SK's CDMO growth platform and provides foothold for U.S. entry07.23.18
-
APIs | Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Cambrex to Acquire Halo Pharma for $425M
Adding drug development and finished dosage capabilities to global API manufacturing network07.23.18
-
Analytical Services | APIs | Capsules
01 Pfizer, Inc.
Headquarters: New York, NY twitter.com@pfizer_news www.pfizer.com Headcount: 90,000 Year Established: 1849 Revenues: $52,546 (-1%) Net Income: $21,308 (+195%) R&D: $7,657 (-3%) TOP SELLING DRUGS…07.20.18
-
APIs | Breaking News | Cytotoxics and High Potency Manufacturing | Excipients | Facilities | Industry News
AGC Expands CDMO Services
Increases GMP-compliant synthetic pharmaceutical intermediate and active ingredient production capacity tenfold07.12.18
-
APIs | Bio News | Breaking News | Facilities | Industry News
Amphastar Announces Expansion Plans
For its subsidiary, Amphastar Nanjing Pharmaceuticals Inc.07.09.18
-
APIs | Bio News | Breaking News | Facilities | Industry News | Injectables
Evonik Invests €35M in CDMO Capabilities
Upgrades North American facilities with new filling lines, production facilities & analytical lab spaceVideos
-
APIs | Breaking News | Industry News | Process Development
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Discovery | Industry News
Enamine and TBD Biodiscovery Collaborate to Provide GMP-based Services
Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery06.20.18
-
APIs | Breaking News | Collaborations & Alliances | Industry News | Process Validation | Regulatory Affairs
WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo
Is first CDMO to support the approval of an innovative drug in China through the MAH pilot program06.14.18
-
APIs | Breaking News | Facilities | Industry News | R&D
Cambrex Expands Generic API R&D Capabilities
Will build new R&D lab at its Milan, Italy site06.12.18
-
APIs | Breaking News | Industry News
